Association Between Cardiovascular Adverse Events and Intravitreal Anti-VEGF Drugs
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cardiovascular Adverse Events With Intravitreal Anti-Vascular Endothelial Growth Factor Drugs: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
JAMA Ophthalmol 2021 Apr 15;[EPub Ahead of Print], N Ngo Ntjam, M Thulliez, G Paintaud, F Salvo, D Angoulvant, PJ Pisella, T Bejan-AngoulvantFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.